Vaxcyte

Director, Global Drug Substance Commercialization, Conjugation

Vaxcyte$210K — $245K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. in Chemical/Biochemical Engineering, Chemistry, Biochemistry, or related field with 10+ years of experience; M.S./M.A. with 12+ years; B.S./B.A. with 16+ years.
  • Extensive experience in glycoconjugate and conjugate production processes, particularly in polysaccharide activation and purification.
  • Demonstrated leadership in Manufacturing Science and Technology (MSAT) or Process Development in supervisory roles.
  • Ability to collaboratively establish strategic plans leveraging deep technical knowledge.
  • Excellent organizational, problem-solving, and strategic planning skills.

Responsibilities

  • Lead strategic and scientific oversight for polysaccharide activation and conjugation.
  • Build and manage a skilled team focusing on conjugation manufacturing processes.
  • Continuously enhance process understanding and robustness for operational optimization.
  • Collaborate with cross-functional teams to support commercial launches of carrier proteins.
  • Ensure effective tech-transfer and integration of new technologies into manufacturing processes.
  • Support manufacturing network through materials management and data analytics.
  • Lead process validation and comparability activities while communicating rationale effectively.

Benefits

  • Comprehensive benefits package including health, dental, and vision coverage.
  • Equity component included in the compensation package.
  • Remote work arrangement with flexibility based on business needs.
  • Opportunities for travel (10-30%) for project-related needs.
Full Job Description
Summary:

The Director for Drug Substance (DS) Commercialization of Conjugation will lead and facilitate launch readiness and commercial supply of glycoconjugate drug substances, including the polysaccharide activation, conjugation, and associated raw materials. This role focuses on technical launch planning and execution by bringing best-practices and coordinating cross-functional efforts for regulatory filings, facility readiness, and launch supplies.

This role also provides leadership to ensure that the organization is equipped to effectively communicate the scientific and commercial rationale for critical raw material manufacturing processes to internal stakeholders, relevant CMOs, and to regulatory agencies. The incumbent will work with the organization to ensure on-time execution and appropriate planning for commercial lifecycle management.

Manufacturing Science and Technology (MSAT) is responsible for successfully and seamlessly transitioning the vaccine process from Process Development to Commercial, developing and executing technical launch and commercialization strategy, continuously improving process robustness through to end of lifecycle, and ensuring best possible patient outcomes while creating value for the enterprise. As part of the Commercial Manufacturing and Supply Chain organization, MSAT will lead the technical and process support for end-to-end commercial manufacturing, including Polysaccharides, Carrier Proteins, and Conjugation across all Drug Substances (DS). The range of activities will include technology transfer support, process characterization experiments in support of validation, process improvement, evaluation of novel process technologies, investigation of process related manufacturing issues, ensuring continuous improvement in process robustness throughout the product life cycle, etc.

Essential Functions:
  • DS Commercialization - Provide strategic and scientific leadership for polysaccharide activation and conjugation processes with internal and external stakeholders and ensure successful execution of launch plans and post-launch commercial activities.
  • Organization - Build a strong and highly-skilled team for the global network with special focus on conjugation manufacturing processes. Support resourcing recommendations on staffing requirements to meet organizational goals.
  • Process robustness - Continuously improve process understanding and process robustness using staff and laboratory resources across the organization to monitor, trend, and optimize operations.
  • Interface - Collaboration with cross-functional teams across the network, including Regulatory, CMC, Quality, Supply Chain, Procurement, and Process Engineering, to drive the successful development and commercial launch of carrier proteins for pipeline products.
  • Tech-transfer new technologies - Ensure robust processes exist to support technical transfers and integration of new technologies.
  • Supporttechnical services - Support of our internal and external manufacturing network, including materials management and data analytics.
  • Process validation and comparability - Provide leadership for the execution of process validation and process comparability activities. Effectively communicate the scientific and commercial rationale for polysaccharide processes to the Manufacturing organization for commercialization
  • Regulatory - Engage In technical reviewing and authoring of regulatory filings and responding to questions received from health authorities. Effectively communicate the scientific and commercial rationale for polysaccharide processes to the Boards of Health for regulatory submissions for commercialization.
  • Communicate - Effectively and efficiently communicate process performance to key stakeholders (internal-facing and external-facing). Connect and build strong working relationships with others, demonstrating strong emotional intelligence and an ability to communicate clearly and persuasively.
  • Leadership - Contribute as DS Commercialization lead for Conjugation and as member of the Global Manufacturing Operations organization, with an aim to ensure effective and efficient delivery of our life-enhancing therapies to our patients.
  • Travel - 10-30% travel required.

Requirements:
  • Degree(s) in Chemical or Biochemical Engineering, Chemistry, Biochemistry, or related discipline with a minimum of 10+ years of relevant experience for Ph.D., 12+ years for M.S./M.A., or 16+ years for B.S./B.A.
  • Extensive experience in conjugate production processes, including polysaccharide activation, conjugation to carrier proteins, and associated purification processes across multiple operational scales. Experience with glycoconjugate vaccines is highly preferred.
  • Leadership experience in MSAT or Process Development in supervisory and/or matrixed team roles.
  • Able to leverage deep technical knowledge in a collaborative manner to establish strategic plans and achieve collective goals.
  • Excellent organization, problem solving and strategic planning skills.
  • Highly skilled in both verbal and written communication with the ability to interact effectively with people of diverse backgrounds and perspectives.
  • Proactively recognizes needs and potential challenges, and directs activities to implement effective solutions.
  • The ability to seek and analyze data from a variety of sources to support decisions and to align others with the organization's overall strategy.
  • An entrepreneurial and creative approach to developing new, innovative ideas that will stretch the organization and push the boundaries within the industry.


Reports to: Sr.Director, Global Drug Substance Commercialization, Conjugation

Work Arrangement (may be adjusted based on business needs, job responsibilities, or changes to company policy): Remote

Location: Remote; prefer Raleigh, NC

Compensation: The compensation package will be competitive and includes comprehensive benefits and an equity component.

Salary Range: $210,000 - $245,000 Remote Salary Range

About Vaxcyte

Vaxcyte is a clinical-stage biotechnology company developing a new generation of vaccines to address some of the most important and deadly infectious diseases worldwide. The company's cell-free protein synthesis platform, comprising the XpressCFTM platform, is capable of rapidly generating protein antigens that can be used in vaccines to protect against bacterial and viral pathogens. Vaxcyte's lead vaccine candidate, VAX-24, is a preclinical, 24-valent pneumococcal conjugate vaccine (PCV) being developed for the prevention of pneumococcal disease. The company is also developing VAX-XP, a PCV with expanded serotype coverage, as well as vaccines for Group A Streptococcus, Group B Streptococcus, and Lyme disease.
Learn more about Vaxcyte
Size
89 employees
Market Cap
$3.6 billion
Industry
Founded
2013
NASDAQ

Similar Jobs

More Jobs at Vaxcyte

More Pharmaceuticals & Biotech Jobs

Find similar Director, Global Drug Substance Commercialization, Conjugation jobs: